The late comedian Rodney Dangerfield was famous for his catchphrase, “I don’t get no respect.” Does Dangerfield’s line apply to some stocks today? Absolutely.
Three Motley Fool contributors think they’ve found surprisingly underrated pharmaceutical stocks to buy right now. Here’s why they picked AstraZeneca (NASDAQ: AZN), Pfizer (NYSE: PFE), and Viatris (NASDAQ: VTRS).
A healthcare behemoth that’s trading at a discount
David Jagielski (AstraZeneca): You wouldn’t expect that one of the largest healthcare stocks in the world would be an underrated buy, but AstraZeneca definitely falls into that category.
Despite its mammoth $250 billion market cap, the stock trades at a fairly light valuation. Based on analyst estimates, it’s trading at just 19 times its estimated future profits. By comparison, the average healthcare stock in the Health Care Select Sector SPDR Fund trades at a multiple of…
